Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study
Top Cited Papers
- 1 March 2006
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 367 (9512) , 740-748
- https://doi.org/10.1016/s0140-6736(06)68304-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Bacterial otitis media: a vaccine preventable disease?Vaccine, 2005
- Immunogenicity and Safety of the Eleven Valent Pneumococcal Polysaccharide-Protein D Conjugate Vaccine in InfantsThe Pediatric Infectious Disease Journal, 2004
- Epidemiology of Acute Otitis Media Caused byStreptococcus pneumoniaeBefore and After Licensure of the 7‐Valent Pneumococcal Protein Conjugate VaccineThe Journal of Infectious Diseases, 2003
- Review of randomized controlled trials on pneumococcal vaccination for prevention of otitis mediaThe Pediatric Infectious Disease Journal, 2003
- The potential of pneumococcal conjugate vaccines for childrenThe Pediatric Infectious Disease Journal, 2002
- Pneumococcal Type 22F Polysaccharide Absorption Improves the Specificity of a Pneumococcal-Polysaccharide Enzyme-Linked Immunosorbent AssayClinical and Diagnostic Laboratory Immunology, 2001
- Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis MediaNew England Journal of Medicine, 2001
- The burden of otitis mediaVaccine, 2000
- Otitis media: back to basicsThe Pediatric Infectious Disease Journal, 1998
- Cox's Regression Model for Counting Processes: A Large Sample StudyThe Annals of Statistics, 1982